3D Breast Anatomy Analysis in Cancer Treatment Planning and Outcome Assessment
癌症治疗计划和结果评估中的 3D 乳房解剖分析
基本信息
- 批准号:7219169
- 负责人:
- 金额:$ 12.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-15 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAlgorithmsAmericanAnatomyAnthropometryAppearanceArtsAutologousBody ImageBreastBreast Cancer TreatmentCancer EtiologyCancer PatientCancer SurvivorCaringCessation of lifeCharacteristicsChargeClinicalCommunicationComplexComputer GraphicsComputer softwareConsensusDataDecision MakingDeformityDescriptorDevelopmentDiagnosisDiagnosticEarly DiagnosisEducationEducational process of instructingEnd PointEstheticsEvaluationEvidence Based MedicineFinancial compensationGoalsGovernmentGuidelinesHealth Care CostsHealth PersonnelHealthcareImageImage AnalysisImageryIncidenceIndividualIndustryInsuranceJudgmentLengthLettersLifeMalignant NeoplasmsMammaplastyMammary Gland ParenchymaMarketingMastectomyMeasurementMeasuresMethodsModalityMorbidity - disease rateMorphologyNational Cancer InstituteNipplesNumbersOperative Surgical ProceduresOutcomeOutcome AssessmentOutcome StudyPatientsPhasePhase I Clinical TrialsPhotogrammetryPhysiciansPositioning AttributePostoperative PeriodPrior SurgeryProceduresProcessPtosisQuality of lifeRateReconstructive Surgical ProceduresRegulationResearchRiskScoreShapesSpecific qualifier valueStandards of Weights and MeasuresStereophotogrammetriesStressSurfaceSurgeonSurgical FlapsSurgical ModelsSurvivorsSystemTechniquesTechnologyTestingThree-Dimensional ImageThree-Dimensional ImagingThree-dimensional analysisTimeTrainingTraumaUnited StatesVendorVisualWomanbasebreast surgerycancer carecancer surgerycancer therapyclinically relevantdesigndigital imagingexpectationexperienceimprovedinstrumentmalignant breast neoplasmmortalitymultidisciplinarypsychologicpsychosocialreconstructionsatisfactionsimulationsizeskillssoftware developmenttechnological innovationtooltreatment planningtrendtwo-dimensional
项目摘要
DESCRIPTION (provided by applicant): Breast cancer is the second leading cause of cancer death in American women. Breast Reconstruction (BR) surgery is an important component of the breast cancer treatment process. It is the surgical procedure used to rebuild breast tissue that has been removed due to cancer surgery. Most importantly, BR surgery is integral to improving the cancer patient's quality of life. However, planning and evaluation of the surgery are done subjectively, and the result is not always satisfactory. We propose to develop tools that will aid surgeons with pre-operative planning and post-operative outcome evaluation. They will also help breast cancer survivors make informed decisions about their treatment choices, by facilitating surgeon-patient communications. Objective outcome analysis will allow more concrete communication with the patient, who can then calibrate her expectations and be more comfortable with her treatment choices. Alterations in appearance (or loss) of the breast have significant psychological and sexual implications in cancer patients. Having recently experienced the trauma and stress associated with the diagnosis and treatment of a life-threatening illness, patients hope to relieve some of the stress and rebuild a positive body image. They hope to achieve a BR result that is attractive and natural looking. Most women who choose BR do so to restore their femininity, image, and body integrity, all of which have been altered negatively by breast cancer therapy. However, there is no information available from an objective analysis of aesthetic outcomes to facilitate the patient's decision making on a procedure that will permanently alter the appearance of her breast. Standards for BR have evolved in the past decade, and patients and surgeons alike expect, symmetrical and natural looking breasts. Surgeons rely on their personal experience and on subjective visual assessment skills to achieve these results. Similarly, aesthetic outcome assessment methods, following surgery, are rather subjective, and are based on observer evaluation of physical changes in breast morphology and symmetry. To date, no consensus exists on how to assess the aesthetic result following BR. With the recent developments in three-dimensional (3D) imaging, there is now an opportunity to develop diagnostic tools that permit 3D treatment planning and objective assessment of post-operative results. The proposed study develops a method for quantitatively describing breast aesthetics. The method will objectively detect relevant changes in breast appearance, making it possible to compare aesthetic outcome between different treatment modalities. A practical technique for quantitative assessment of breast appearance would improve breast cancer care in several ways. Key applications include enabling personalized, evidence-based medicine, surgical planning, setting fair charges, and surgery education. Breast cancer is the most common life-threatening malignancy in women. Treatment advances and early detection have resulted in decreased mortality from breast cancer despite a steadily rising incidence in the United States between 1990 and 2002. Encouraged by this trend and other evidence of progress, the National Cancer Institute (NCI) has issued a challenge goal to eliminate suffering and death from cancer by the year 2015. Achieving this goal for women requires addressing the psychosocial morbidity caused by physical deformities of the breast that result from cancer treatment. A major step towards minimizing treatment-related deformities is to improve the surgical techniques of breast reconstruction. Developing quantitative tools for assessing the aesthetic outcome of BR is thus a significant step in the right direction. The goal of this Phase I study is to develop software tools that would aid the surgeon in quantifying and interpreting 3D data in a meaningful and clinically relevant fashion. 3D measurements would also be invaluable for relating patient and surgical variables meaningfully to aesthetic outcomes, and for comparing the outcomes of different kinds of breast cancer treatments (e.g., different reconstruction procedures).
描述(由申请人提供):乳腺癌是美国女性癌症死亡的第二大原因。乳房再造(BR)手术是乳腺癌治疗过程的重要组成部分。它是用于重建因癌症手术而被切除的乳房组织的外科手术。最重要的是,BR手术对于改善癌症患者的生活质量是不可或缺的。然而,手术的计划和评估都是主观的,结果并不总是令人满意的。我们建议开发工具,帮助外科医生进行术前规划和术后结果评估。他们还将通过促进外科医生与患者的沟通,帮助乳腺癌幸存者就他们的治疗选择做出明智的决定。客观的结果分析将允许与患者进行更具体的沟通,然后患者可以调整她的期望,并对她的治疗选择更满意。乳房外观的改变(或消失)对癌症患者有重要的心理和性影响。最近经历了与诊断和治疗危及生命的疾病相关的创伤和压力,患者希望减轻一些压力并重建积极的身体形象。他们希望达到一个BR的结果是有吸引力的和自然的外观。大多数选择BR的女性这样做是为了恢复她们的女性气质,形象和身体完整性,所有这些都被乳腺癌治疗所负面改变。然而,没有从美学结果的客观分析中获得的信息,以帮助患者决定是否进行永久改变其乳房外观的手术。在过去的十年中,BR的标准已经发展,患者和外科医生都希望乳房对称和自然。外科医生依靠他们的个人经验和主观视觉评估技能来实现这些结果。同样,手术后的美学结果评估方法相当主观,并且基于观察者对乳房形态和对称性的物理变化的评价。迄今为止,对于如何评估BR后的美学结果尚未达成共识。随着三维(3D)成像的最新发展,现在有机会开发允许3D治疗计划和术后结果客观评估的诊断工具。该研究开发了一种定量描述乳房美学的方法。该方法将客观地检测乳房外观的相关变化,从而可以比较不同治疗方式之间的美学结果。定量评估乳房外观的实用技术将在几个方面改善乳腺癌护理。主要应用包括实现个性化,循证医学,手术规划,设置公平的收费和手术教育。乳腺癌是女性最常见的危及生命的恶性肿瘤。尽管1990年至2002年美国乳腺癌的发病率稳步上升,但治疗的进步和早期发现导致了乳腺癌死亡率的下降。在这一趋势和其他进展证据的鼓舞下,国家癌症研究所(NCI)发布了一项挑战目标,即到2015年消除癌症造成的痛苦和死亡。要为妇女实现这一目标,就必须解决癌症治疗造成的乳房物理畸形所造成的心理社会疾病。减少治疗相关畸形的一个主要步骤是改进乳房再造的手术技术。因此,开发用于评估BR美学结果的定量工具是朝着正确方向迈出的重要一步。本I期研究的目标是开发软件工具,帮助外科医生以有意义和临床相关的方式量化和解释3D数据。3D测量对于将患者和手术变量有意义地与美学结果相关联以及比较不同种类的乳腺癌治疗的结果(例如,不同的重建过程)。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Automated Identification of Fiducial Points on 3D Torso Images.
- DOI:10.4137/becb.s11800
- 发表时间:2013
- 期刊:
- 影响因子:2.8
- 作者:Kawale MM;Reece GP;Crosby MA;Beahm EK;Fingeret MC;Markey MK;Merchant FA
- 通讯作者:Merchant FA
Validation of stereophotogrammetry of the human torso.
- DOI:10.4137/bcbcr.s6352
- 发表时间:2011-02-15
- 期刊:
- 影响因子:0
- 作者:Lee J;Kawale M;Merchant FA;Weston J;Fingeret MC;Ladewig D;Reece GP;Crosby MA;Beahm EK;Markey MK
- 通讯作者:Markey MK
3D Symmetry Measure Invariant to Subject Pose During Image Acquisition.
- DOI:10.4137/bcbcr.s7140
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Kawale M;Lee J;Leung SY;Fingeret MC;Reece GP;Crosby MA;Beahm EK;Markey MK;Merchant FA
- 通讯作者:Merchant FA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fatima Aziz Merchant其他文献
Fatima Aziz Merchant的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fatima Aziz Merchant', 18)}}的其他基金
3D Image Analysis Software for Breast Reconstruction Surgical Planning, Outcome Assessment & Clinical Consultation
用于乳房重建手术规划、结果评估的 3D 图像分析软件
- 批准号:
10484568 - 财政年份:2022
- 资助金额:
$ 12.53万 - 项目类别:
3D Image Analysis Software for Breast Reconstruction Surgical Planning, Outcome Assessment & Clinical Consultation
用于乳房重建手术规划、结果评估的 3D 图像分析软件
- 批准号:
10589908 - 财政年份:2022
- 资助金额:
$ 12.53万 - 项目类别:
A Virtual Reality Environment for Genomic Data Visualization
基因组数据可视化的虚拟现实环境
- 批准号:
7218900 - 财政年份:2007
- 资助金额:
$ 12.53万 - 项目类别:
Low Cost Automated Urinalysis using Spectral Data
使用光谱数据进行低成本自动化尿液分析
- 批准号:
6883492 - 财政年份:2005
- 资助金额:
$ 12.53万 - 项目类别:
Automated Detection of Gene Duplications or Deletions
自动检测基因重复或缺失
- 批准号:
6874478 - 财政年份:2000
- 资助金额:
$ 12.53万 - 项目类别:
Automated Detection of Gene Duplications or Deletions
自动检测基因重复或缺失
- 批准号:
6742066 - 财政年份:2000
- 资助金额:
$ 12.53万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 12.53万 - 项目类别:
Research Grant














{{item.name}}会员




